2 reports

Data also indicated that PledPharma s drug candidate has potential to reduce the risk of liver transplantation in late incoming patients, at a time where the effect of NAC is impaired or exhausted.

  • Anesthetics
  • Opioid
  • United States
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.

Data also indicated that PledPharma s drug candidate has potential to reduce the risk of liver transplantation in late incoming patients, at a time where the effect of NAC is impaired or exhausted.

  • Anesthetics
  • Pharmaceutical
  • United States
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.